Sonya J. Snedecor, Ph.D.
Affiliations: | 2002 | University of California, Los Angeles, Los Angeles, CA |
Area:
Biostatistics Biology, ImmunologyGoogle:
"Sonya Snedecor"Parents
Sign in to add mentorCarol Newton | grad student | 2002 | UCLA | |
(Mathematical models to evaluate the optimal treatment of HIV -1 infection and the response of drug -resistant variants.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Schultz BG, Diakite I, Carter JA, et al. (2021) Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis. Journal of Managed Care & Specialty Pharmacy. 27: 1592-1600 |
Schultz R, Diakite I, Carter JA, et al. (2020) Su1813 COST-EFFECTIVENESS OF VEDOLIZUMAB IV VERSUS ADALIMUMAB SC FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS Gastroenterology. 158: S-658 |
Snedecor SJ, Radford M, Kratochvil D, et al. (2019) Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis. Bmc Infectious Diseases. 19: 484 |
Ektare V, Fox CP, Taylor RS, et al. (2016) Attainment of Complete Remission Is Significantly Associated with Longer Survival Outcomes in Relapsed/Refractory (R/R) CLL: A Meta-Analysis Blood. 128: 2045-2045 |
McDonald M, Patel DA, Keith MS, et al. (2015) Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review. The Ocular Surface |
Qin L, Luo X, Zou KH, et al. (2015) Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in vulnerable elderly population in the United States. Journal of Medical Economics. 1-25 |
Howlett C, Snedecor SJ, Landsburg DJ, et al. (2015) Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. British Journal of Haematology |
Mahon F, Tran-Duy A, Ocampo RG, et al. (2015) Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model Blood. 126: 5154-5154 |
Saglio G, Snedecor SJ, Ji X, et al. (2015) Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase Blood. 126: 1579-1579 |
Snedecor SJ, Howlett C, Mato A. (2015) Synthesis Of Multiple Types Of Survival Data Within A Weibull Proportional Hazards Meta-Analysis: Treatment Outcomes In Patients With Double Hit Lymphoma (DHL) Value in Health. 18 |